.INVESTIGATION HIGHLIGHT.06 August 2024.
A large randomized measured test with cisgender females highlights the obstacles of obedience to an everyday dental preexposure prophylaxis program as well as demonstrates that twice-yearly treatment of lenacapavir may maintain helpful HIV avoidance amounts over 6 months.